HEADER HORMONE/GROWTH FACTOR 05-MAY-04 1T5Q TITLE SOLUTION STRUCTURE OF GIP(1-30)AMIDE IN TFE/WATER COMPND MOL_ID: 1; COMPND 2 MOLECULE: GASTRIC INHIBITORY POLYPEPTIDE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 1-30; COMPND 5 SYNONYM: GIP, GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED, THE SEQUENCE SOURCE 4 OF THE PEPTIDE CAN BE NATURALLY FOUND IN HOMO SAPIENS (HUMAN) KEYWDS GIP, MOLECULAR MODELLING, HELIX, DIABETES, OBESITY, HORMONE-GROWTH KEYWDS 2 FACTOR COMPLEX EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR I.ALANA,C.M.HEWAGE,J.P.G.MALTHOUSE,J.C.PARKER,V.A.GAULT,F.P.M.O'HARTE REVDAT 3 02-MAR-22 1T5Q 1 REMARK REVDAT 2 24-FEB-09 1T5Q 1 VERSN REVDAT 1 16-NOV-04 1T5Q 0 JRNL AUTH I.ALANA,C.M.HEWAGE,J.P.G.MALTHOUSE,J.C.PARKER,V.A.GAULT, JRNL AUTH 2 F.P.M.O'HARTE JRNL TITL NMR STRUCTURE OF THE GLUCOSE-DEPENDENT INSULINOTROPIC JRNL TITL 2 POLYPEPTIDE FRAGMENT, GIP(1-30)AMIDE. JRNL REF BIOCHEM.BIOPHYS.RES.COMMUN. V. 325 281 2004 JRNL REFN ISSN 0006-291X JRNL PMID 15522230 JRNL DOI 10.1016/J.BBRC.2004.10.033 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR 3.5, SYBYL 6.81 REMARK 3 AUTHORS : BRUKER (XWINNMR), TRIPOS (SYBYL) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1T5Q COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-MAY-04. REMARK 100 THE DEPOSITION ID IS D_1000022345. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 3.0 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 2MM GIP(1-30)AMIDE, 50% H2O, 50% REMARK 210 D3-TFE REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : DQF-COSY; 2D TOCSY; 2D NOESY; 1D REMARK 210 VARIABLE TEMPERATURE; 1D D2O REMARK 210 EXCHANGE REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 900 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XWINNMR 3.5, SYBYL 6.81, CYANA REMARK 210 1.0.6 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS, REMARK 210 SIMULATED ANNEALING, CONJUGATE- REMARK 210 GRADIENT MINIMISATION, POWELL REMARK 210 MINIMISATION REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : CYANA TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: THESE STRUCTURES WERE DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 2 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -4.8 DEGREES REMARK 500 3 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -4.8 DEGREES REMARK 500 4 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -4.8 DEGREES REMARK 500 5 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -4.9 DEGREES REMARK 500 6 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -4.9 DEGREES REMARK 500 8 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -4.9 DEGREES REMARK 500 12 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -4.9 DEGREES REMARK 500 13 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -5.0 DEGREES REMARK 500 14 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -4.9 DEGREES REMARK 500 15 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -4.9 DEGREES REMARK 500 18 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -4.8 DEGREES REMARK 500 20 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -4.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLN A 29 45.69 -108.40 REMARK 500 2 GLN A 29 46.10 -109.38 REMARK 500 5 GLN A 29 53.69 -102.30 REMARK 500 6 GLN A 29 56.56 -107.33 REMARK 500 7 THR A 5 44.87 -107.24 REMARK 500 7 GLN A 29 74.43 -103.29 REMARK 500 8 ALA A 2 170.38 60.22 REMARK 500 9 ALA A 2 61.89 -153.83 REMARK 500 9 GLU A 3 84.22 -68.26 REMARK 500 9 GLN A 29 62.02 -104.56 REMARK 500 10 GLN A 29 67.52 -100.65 REMARK 500 12 THR A 5 46.33 -102.49 REMARK 500 14 GLU A 3 74.45 -69.22 REMARK 500 14 GLN A 29 46.45 -102.43 REMARK 500 15 GLN A 29 57.67 -100.80 REMARK 500 16 ALA A 2 59.48 -101.77 REMARK 500 16 THR A 5 43.32 -105.30 REMARK 500 16 GLN A 29 77.16 -106.58 REMARK 500 17 GLN A 29 71.61 -113.32 REMARK 500 18 ALA A 2 179.44 58.15 REMARK 500 18 GLN A 29 55.07 -103.27 REMARK 500 19 GLN A 29 50.56 -101.95 REMARK 500 20 ALA A 2 62.33 -109.28 REMARK 500 20 GLU A 3 81.96 -69.72 REMARK 500 20 THR A 5 49.94 -103.63 REMARK 500 20 GLN A 29 56.52 -100.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR DBREF 1T5Q A 1 30 UNP P09681 GIP_HUMAN 52 81 SEQRES 1 A 30 TYR ALA GLU GLY THR PHE ILE SER ASP TYR SER ILE ALA SEQRES 2 A 30 MET ASP LYS ILE HIS GLN GLN ASP PHE VAL ASN TRP LEU SEQRES 3 A 30 LEU ALA GLN LYS HELIX 1 1 PHE A 6 ALA A 28 1 23 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1